We are live on
!
Find out more
Hudson Bay Capital Management Portfolio holdings
AUM
$29B
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
+3.26%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$30.3B
AUM Growth
+$259M
(+0.86%)
Cap. Flow
+$4.21M
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
25.78%
Holding
1,635
New
443
Increased
264
Reduced
288
Closed
475
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$412M |
| 2 |
Microsoft
MSFT
|
+$384M |
| 3 |
Netflix
NFLX
|
+$293M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$253M |
| 5 |
Broadcom
AVGO
|
+$190M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$421M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$172M |
| 3 |
TSMC
TSM
|
+$149M |
| 4 |
K
Kellanova
K
|
+$100M |
| 5 |
UnitedHealth
UNH
|
+$86.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.06% |
| 2 | Financials | 8.07% |
| 3 | Consumer Discretionary | 6.89% |
| 4 | Healthcare | 5.17% |
| 5 | Communication Services | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Avalo Therapeutics
AVTX
$1.05B
| $305K | ﹤0.01% |
+16,771
| New | +$283K |
|
902
Cabaletta Bio
CABA
$465M
| $304K | ﹤0.01% |
+138,729
| New | +$344K |
|
|
GSRFR
903
GSR IV Acquisition Corp Rights
GSRFR
| $303K | ﹤0.01% |
+128,571
| New | +$317K |
|
|
RAPT
904
DELISTED
RAPT Therapeutics
RAPT
| $301K | ﹤0.01% |
+8,900
| New | +$276K |
|
905
Duos Technologies
DUOT
$293M
| $297K | ﹤0.01% |
+26,441
| New | +$248K |
|
|
CTNM
906
Contineum Therapeutics
CTNM
$564M
| $296K | ﹤0.01% |
+25,938
| New | +$296K |
|
907
Prenetics Global
PRE
$318M
| $296K | ﹤0.01% |
+18,774
| New | +$273K |
|
908
iShares Russell 2000 Value ETF
IWN
$14.6B
| $294K | ﹤0.01% |
+1,622
| New | +$291K |
|
|
FIG
909
Figma
FIG
$12.7B
| $293K | ﹤0.01% |
7,832
-9,818
| -56% | -$444K |
|
910
Comstock
LODE
$265M
| $292K | ﹤0.01% |
+77,678
| New | +$264K |
|
911
Virgin Galactic
SPCE
$500M
| $291K | ﹤0.01% |
+90,633
| New | +$341K |
|
912
Fossil Group
FOSL
$311M
| $288K | ﹤0.01% |
+76,484
| New | +$216K |
|
|
TTAN
913
ServiceTitan Inc
TTAN
$8.78B
| $285K | ﹤0.01% |
+2,680
| New | +$262K |
|
|
DMAAR
914
Drugs Made In America Acquisition Corp Rights
DMAAR
| $284K | ﹤0.01% |
1,800,000
| – | – |
|
915
CALL
Vor Biopharma
VOR
$1.21B
| $278K | ﹤0.01% |
21,250
| – | – |
|
|
DMIIR
916
Drugs Made In America Acquisition II Corp Right
DMIIR
| $276K | ﹤0.01% |
+1,969,030
| New | +$281K |
|
917
Regencell Bioscience
RGC
$2.5B
| $275K | ﹤0.01% |
+13,107
| New | +$213K |
|
918
InfuSystem Holdings
INFU
$244M
| $274K | ﹤0.01% |
+30,508
| New | +$292K |
|
919
Ciena
CIEN
$61.2B
| $274K | ﹤0.01% |
+1,170
| New | +$227K |
|
920
ProShares VIX Short-Term Futures ETF
VIXY
$189M
| $273K | ﹤0.01% |
10,647
-4,353
| -29% | -$138K |
|
921
Tractor Supply
TSCO
$19B
| $271K | ﹤0.01% |
5,417
-100,355
| -95% | -$5.4M |
|
922
Amtech Systems
ASYS
$279M
| $270K | ﹤0.01% |
+21,553
| New | +$194K |
|
|
THS
923
DELISTED
Treehouse Foods
THS
| $268K | ﹤0.01% |
11,347
| – | – |
|
924
Everspin Technologies
MRAM
$415M
| $267K | ﹤0.01% |
+28,736
| New | +$273K |
|
925
Energy Vault
NRGV
$710M
| $265K | ﹤0.01% |
+57,440
| New | +$220K |
|
Similar funds
PCH
N
TWC
FDCDDQ
Hudson Bay Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Hudson Bay Capital Management held 1,635 positions worth $30.3B, up 0.86% from $30.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Hudson Bay Capital Management's Q4 2025 filing shows 443 new, 264 increased, 288 reduced and 475 closed positions. Its largest new stake was Vertiv: 964,604 shares worth $156M. The largest sale was Amazon, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Hudson Bay Capital Management's largest Q4 2025 buy was Vertiv: 964,604 shares worth $156M.
- Hudson Bay Capital Management added most to Palantir in Q4 2025, an estimated $412M increase.
- Hudson Bay Capital Management's biggest Q4 2025 reduction was Amazon, cutting an estimated $421M.
- Hudson Bay Capital Management fully exited Kellanova in Q4 2025, selling an estimated $100M.
- Hudson Bay Capital Management's ten largest holdings make up 26% of its $30.3B portfolio in Q4 2025.
- Hudson Bay Capital Management opened 443 new positions and closed 475 in Q4 2025.
- Hudson Bay Capital Management's portfolio value rose 0.86% quarter-over-quarter to $30.3B.
Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.